Global X China Little Giant ETF - Global X ETFs Hong Kong
1746066119

Global X China Little Giant ETF

2815 HKD

Invest in 2815

Important Information

Investors should not base investment decisions on this website/material/video alone. Please refer to the Prospectus for details including product features and the risk factors. Investment involves risks. Past performance is not indicative of future performance. There is no guarantee of the repayment of the principal. Investors should note:

  • Global X China Little Giant ETF’s (the “Fund’s”) objective is to provide investment results that, before fees and expenses, closely correspond to the performance of the Solactive China Little Giant Index (the “Index”).
  • The Index is a new index. The Index has minimal operating history by which investors can evaluate its previous performance. There can be no assurance as to the performance of the Index. The Fund may be riskier than other exchange traded funds tracking more established indices with longer operating history.
  • The Fund may invest in small and/or mid-capitalisation companies which may have lower liquidity and their prices are more volatile to adverse economic developments than those of larger capitalisation companies in general.
  • The Fund’s investments are concentrated in companies which are characterised by relatively higher volatility in price performance. The Sub-Fund may be exposed to risks associated with different sectors and themes including semiconductor, industrial, pharmaceutical, energy and technology. Fluctuations in the business for companies in these sectors or themes will have an adverse impact on the net asset value of the Sub-Fund. Some of the companies classified as the Little Giants have a relatively short operating history. Such companies also face intense competition and rapid changes could render the products and services offered by these companies obsolete, which may have an adverse effect on profit margins. They may be more susceptible to risks of loss or impairment of intellectual property rights or licences, cyber security risks resulting in undesirable legal, financial, operational and reputational consequences affecting those companies.
  • The Mainland China is an emerging market. The Fund invests in Mainland Chinese companies which may involve increased risks and special considerations not typically associated with investment in more developed markets, such as liquidity risk, currency risks or control, political and economic uncertainties, legal and taxation risks, settlement risks, custody risk and the likelihood of a high degree of volatility. Securities exchanges in the Mainland Chinese markets typically have the right to suspend or limit trading in any security traded on the relevant exchange. The government or the regulators may also implement policies that may affect the financial markets. All these may have a negative impact on the Fund.
  • Listed companies on the ChiNext market and/or STAR Board are subject to higher fluctuation on stock prices and liquidity risk, over-valuation risk, less stringent regulation risk, delisting risk and concentration risk.
  • As part of the securities lending transactions, there is a risk of shortfall of collateral value due to inaccurate pricing of the securities lent or change of value of securities lent. This may cause significant losses to the Fund. The borrower may fail to return the securities in a timely manner or at all. The Fund may suffer from a loss or delay when recovering the securities lent out. This may restrict the Fund’s ability in meeting delivery or payment obligations from redemption requests.
  • The Fund’s synthetic replication strategy will involve investing up to 50% of its net asset value in financial derivative instruments (“FDIs”), mainly funded total return swap transaction(s) through one or more counterparty(ies). Risks associated with FDIs include counterparty/credit risk, liquidity risk, valuation risk, volatility risk and over-the-counter transaction risk. FDIs are susceptible to price fluctuations and higher volatility, and may have large bid and offer spreads and no active secondary markets. The leverage element/component of an FDI can result in a loss significantly greater than the amount invested in the FDI by the Fund.
  • The trading price of the Shares on the SEHK is driven by market factors such as the demand and supply of the Shares. Therefore, the Shares may trade at a substantial premium or discount to the Fund’s Net Asset Value.
  • Payments of distributions out of capital or effectively out of capital amounts to a return or withdrawal of part of an investor’s original investment or from any capital gains attributable to that original investment. Any such distributions may result in an immediate reduction in the Net Asset Value per Share of the Fund and will reduce the capital available for future investment.

Why Global X China Little Giant ETF? Product Flyer 

  • China‘s economy is transitioning to high-quality one. Specialized and sophisticated SMEs「專精特新小巨人」is a key tool for China to achieve it.
  • “Little Giant” companies are high-quality small-cap companies in China’s strategic industries. They are industry leaders in niche markets and play a crucial role in the supply chain for China’s high-end manufacturing sector.
  • “Little Giant” companies receive strong support from the government and society.

Fund InformationAs of 29 Apr 2025

Fund Inception Date 17 Nov 2023
SEHK Listing Date 20 Nov 2023
Fiscal Year Ending 31 Mar
Ongoing Charges Over A Year ^ 0.68%
Distribution Frequency Annually (usually in May of each year) at the Manager’s discretion.*
NAV Per Share RMB $43.90
Monthly Report
^ The Fund adopts a single management fee structure, whereby a single flat fee will be paid out of the assets of the Fund to cover all of the costs, fees and expenses of the Fund. Click to learn more. * Dividend is not guaranteed, distributions may be made out of capital or income at the Manager’s discretion. Positive distribution does not imply positive return. Please refer to the IMPORTANT INFORMATION section above and the Fund’s prospectus for further details.

Index Information 1 As of 29 Apr 2025

Underlying Index Solactive China Little Giant Index 2
Index Type Net Total Return
Base Currency RMB
Closing Level 124.90
Change 0.57
Change % 0.46%

Trading InformationAs of 29 Apr 2025

Exchange Hong Kong Exchange
Stock Code 2815
ISIN HK0000945656
Board Lot Size 50 Units
Trading Currency HKD
Base Currency RMB
Total Net Asset Value $34,656,308.55
Outstanding Units 739,750

ETF Summary

Global X China Little Giant ETF provides investors with access to potential small- and medium-sized companies in strategic areas such as semiconductors, advanced manufacturing, pharmaceuticals and clean energy etc. With the continuous development of proprietary products and technologies, the innovation and profitability of Chinese specialized "Little Giant" companies will be further enhanced, and they are expected to achieve even faster growth, and investors in this ETF may benefit from the continued transformation of Chinese economic structure and the upgrading of industrial chain.

The investment objective is to provide investment returns that closely correspond to the performance of the Solactive China Little Giant Index (the "Index"), net of fees and expenses.

ETF Prices

* Market prices are provided on a 15-minute delayed basis by ICE Data Services. (See terms and conditions)

Daily NAV per Unit5As of 29 Apr 2025

NAV Change % Change
Official NAV per Unit in RMB $43.90 $0.20 0.45%
NAV per Unit in HKD 3 $46.85 $0.21 0.45%

Performance As of 29 Apr 2025

Cumulative Return Fund NAV (%) Benchmark (%)
1 Mth -3.61 -3.57
3 Mths 0.97 1.15
6 Mths -2.17 -1.79
1 Yr 0.19 1.09
YTD 2.46 2.75
Since Inception -12.87 -11.87
Calendar Year Return Fund NAV (%) Benchmark (%)
2024 -11.77 -11.02
2023 - -
2022 - -
2021 - -
2020 - -
Source: Mirae Asset Global Investments (Hong Kong) Limited.
• Past performance information is not indicative of future performance. Investors may not get back the full amount invested.
• The computation basis of the performance is based on the calendar year end, NAV-to-NAV, with dividend reinvested.
• These figures show by how much the Fund increased or decreased in value during the calendar year shown.
• Performance data has been calculated in RMB including ongoing charges and excluding trading costs on SEHK you might have to pay.
• Where no past performance is shown there was insufficient data available in that year to provide performance.
• The Index of the Fund is Solactive China Little Giant Index.
• Fund inception date: 17 Nov, 2023.

Exposure As of 31 Mar 2025

    Weight (%)
Information Technology 61.1
Health Care 18.2
Industrials 12.1
Materials 6.2
Consumer Discretionary 2.3
Cash 0.1
    Weight (%)
China 99.9
Cash 0.1

Holdings Overview As of 29 Apr 2025

Total Net Asset Value (in HKD) Total Net Asset Value (in USD) Total Net Asset Value (in RMB) Number of Securities Securities (%) Cash and Cash Equivalent (%)
34,656,308.55 4,466,918.70 32,474,052.24 50 99.91 0.09

Daily HoldingsAs of 29 Apr 2025

Name of Securities Exchange Ticker Exchange Market Price (in RMB) Number of Shares Held Market Value (in RMB) Net Assets (%)
ROCKCHIP ELECTRONICS CO L 603893 CH Shanghai 154.97 11,798 1,828,336.06 5.63
SG MICRO CORP 300661 CH Shenzhen 104.22 16,860 1,757,149.20 5.41
IMEIK TECHNOLOGY DEVELOPME 300896 CH Shenzhen 175.00 8,996 1,574,300.00 4.85
ACM RESEARCH SHANGHAI I 688082 CH Shanghai 103.05 14,999 1,545,646.95 4.76
APT MEDICAL INC 688617 CH Shanghai 423.95 3,300 1,399,035.00 4.31
SHANGHAI BOCHU ELECTRONIC 688188 CH Shanghai 190.39 6,399 1,218,305.61 3.75
SUZHOU TFC OPTICAL COMMUNI 300394 CH Shenzhen 67.68 16,977 1,149,003.36 3.54
ASYMCHEM LABORATORIES TIAN 002821 CH Shenzhen 81.90 12,267 1,004,667.30 3.09
HWATSING TECHNOLOGY 688120 CH Shanghai 165.50 5,900 976,450.00 3.01
JIANGSU JIEJIE MICROELECTR 300623 CH Shenzhen 28.92 30,720 888,422.40 2.74
PIOTECH INC 688072 CH Shanghai 163.80 5,400 884,520.00 2.72
ANJI MICROELECTRONICS TECH 688019 CH Shanghai 180.80 4,299 777,259.20 2.39
HEBEI SINOPACK ELECTRONIC 003031 CH Shenzhen 46.56 16,112 750,174.72 2.31
KINGSEMI 688037 CH Shanghai 98.40 7,599 747,741.60 2.30
STARPOWER SEMICONDUCTOR LT 603290 CH Shanghai 81.53 8,709 710,044.77 2.19
KEBODA TECHNOLOGY 603786 CH Shanghai 52.90 13,105 693,254.50 2.13
CHENGDU JIACHI ELECTRONIC 688708 CH Shanghai 46.50 14,500 674,250.00 2.08
WILLFAR INFORMATION TECHNO 688100 CH Shanghai 36.22 18,099 655,545.78 2.02
FUJIAN TORCH ELECTRON TECH 603678 CH Shanghai 39.21 16,481 646,220.01 1.99
SUZHOU NOVOSENSE MICROELEC 688052 CH Shanghai 190.72 3,200 610,304.00 1.88
BEIJING HUAFENG TEST & CON 688200 CH Shanghai 153.55 3,800 583,490.00 1.80
SINOFIBERS TECHNOLOGY CO L 300777 CH Shenzhen 35.68 15,537 554,360.16 1.71
IRAY GROUP 688301 CH Shanghai 123.00 4,399 541,077.00 1.67
ANHUI XDLK MICROSYSTEM COR 688582 CH Shanghai 66.90 7,999 535,133.10 1.65
HARBIN BOSHI AUTOMATION 002698 CH Shenzhen 16.35 32,598 532,977.30 1.64
XI'AN TRIANGLE DEFENSE 300775 CH Shenzhen 24.49 19,949 488,551.01 1.50
DALIAN BAIAO CHEMICALS 603360 CH Shanghai 28.00 17,446 488,488.00 1.50
CHINA LEADSHINE TECHNOLOGY 002979 CH Shenzhen 46.49 10,396 483,310.04 1.49
WUXI NCE POWER 605111 CH Shanghai 30.45 15,068 458,820.60 1.41
EYEBRIGHT MEDICAL TECHNOLO 688050 CH Shanghai 78.11 5,700 445,227.00 1.37
SHANGHAI FULLHAN MICROELEC 300613 CH Shenzhen 46.90 8,423 395,038.70 1.22
CHENGDU RML TECHNOLOGY 301050 CH Shenzhen 44.60 8,802 392,569.20 1.21
CHENGDU CORPRO TECHNOLOGY 300101 CH Shenzhen 16.11 24,039 387,268.29 1.19
SHANGHAI GENTECH 688596 CH Shanghai 37.82 10,099 381,944.18 1.18
FORTIOR TECHNOLOGY SHENZHE 688279 CH Shanghai 227.66 1,689 384,517.74 1.18
JOINN LABORATORIES CHINA C 603127 CH Shanghai 15.49 23,882 369,932.18 1.14
PYLON TECHNOLOGIES 688063 CH Shanghai 40.65 9,000 365,850.00 1.13
SHANGHAI MICROPORT ENDOVAS 688016 CH Shanghai 83.75 4,300 360,125.00 1.11
SOUTHCHIP SEMICONDUCTOR TE 688484 CH Shanghai 33.80 10,599 358,246.20 1.10
DONGGUAN AOHAI TECHNOLOGY 002993 CH Shenzhen 35.63 9,930 353,805.90 1.09
GIANTEC SEMICONDUCTOR CORP 688123 CH Shanghai 71.61 4,900 350,889.00 1.08
QINGDAO YUNLU ADVANCED MAT 688190 CH Shanghai 91.25 3,600 328,500.00 1.01
NOVORAY CORP 688300 CH Shanghai 54.76 5,900 323,084.00 0.99
HONGYUAN GREEN ENERGY CO L 603185 CH Shanghai 12.91 24,352 314,384.32 0.97
WUHAN TIANYUAN ENVIRONMENT 301127 CH Shenzhen 15.63 20,139 314,772.57 0.97
SICHUAN INJET ELECTRIC 300820 CH Shenzhen 39.49 7,764 306,600.36 0.94
SHANGHAI HANBELL PRECISE 002158 CH Shenzhen 16.54 18,162 300,399.48 0.93
JIANGSU TOLAND ALLOY CO LT 300855 CH Shenzhen 21.82 13,850 302,207.00 0.93
AMOY DIAGNOSTICS 300685 CH Shenzhen 20.82 13,866 288,690.12 0.89
SHIJIAZHUANG SHANGTAI TECH 001301 CH Shenzhen 50.34 5,242 263,882.28 0.81
Source: Mirae Asset, Bloomberg
Holdings are subject to change. Cash, where shown, includes other assets and liabilities, such as payables and receivables.
20250429.45470.45845733129575124.9

Tracking Difference / Error

Tracking Difference / Tracking Error

Tracking Difference
Tracking difference is the return difference between the Fund and the Underlying Index over a certain period of time.
Tracking Error
Tracking error measures how consistently the Fund follows the Underlying Index. It is the volatility (measured by standard deviation) of that return difference.

Tracking Difference (TD)

Fund Listing Date:20 Nov 2023

Estimated Annual TD: -2.00%

TD (Since Listing): N/A%

TD for Calendar Year 2024:-0.75%

Tracking Error (TE)

Fund Listing Date:20 Nov 2023

Rolling 1 Year TE^ :N/A%

^ Annualized based on the number of dealing days in the past year when daily TD is calculated.


Graph for Tracking Difference

ETFs performance is calculated on an NAV to NAV basis and assumes reinvestment of distribution.

Hover over the chart points for details

Market Makers 6

Mirae Asset Securities Co., Ltd

Optiver Trading Hong Kong Limited

Participating Dealers 7

China Merchants Securities (HK) Co., Limited

DBS Vickers (Hong Kong) Limited

Haitong International Securities Company Limited

Mirae Asset Securities (HK) Limited

Valuable Capital Limited

Back to Top

You’re now leaving Global X Hong Kong website


Clicking "Confirm" below will take you to an independent site. Information and services provided on this independent site are not reviewed by, guaranteed by, or Global X Hong Kong. This independent site's terms and conditions, privacy and security policies, or other legal information may be different from those of Global X Hong Kong’s site. Global X Hong Kong is not liable for any direct or indirect technical or system issues, consequences, or damages arising from your use of this independent website.



CancelConfirm

This website is intended for Hong Kong investors only. Your use of this website means you agree to our Terms of use. This website is strictly for informational purposes only and does not constitute a representation that any investment strategy is suitable or appropriate for an investor’s individual circumstances. In 2018, Global X was acquired by Mirae Asset Global Investments and Mirae Asset Global Investments Co., Ltd. is the parent company of Mirae Asset Global Investments (Hong Kong) Limited.

The information contained in this website is for information purposes only and does not, constitute any recommendations, offer or solicitation to buy, sell or subscribe to any securities or financial instruments in any jurisdiction. Investment involves risk. It cannot be guaranteed that the performance of the Product will generate a return and there may be circumstances where no return is generated or the amount invested is lost. Past performance is not indicative of future performance.

Before making any investment decision to invest in the Product, investors should read the Product’s prospectus for details and the risk factors. Investors should ensure they fully understand the risks associated with the Product and should also consider their own investment objective and risk tolerance level. Investors are advised to seek independent professional advice before making any investments.

Certain information contained in this website is compiled from third party sources. Whilst Mirae Asset Global Investments (Hong Kong) Limited (“Mirae Asset HK”), the Manager of the Product, has, to the best of its endeavor, ensured that such, information is accurate, complete and up-to-date, and has taken care in accurately reproducing the information. Mirae Asset HK accepts no liability for, any loss or damage of any kind resulting out of the unauthorized use of this website.

The Products are not sponsored, endorsed, issued, sold or promoted by their index providers. For details of an index provider including any disclaimer, please refer to the relevant Product’s offering documents.

The contents of this website is prepared and maintained by Mirae Asset Global Investments (Hong Kong) Limited and has not been reviewed by the Securities and Futures Commission of Hong Kong.